EFS and OS among patients with newly diagnosed MM according to the presence or absence of common recurrent translocations and Amp1q21. A Kaplan-Meier analysis of EFS (left) and OS (right) in patients with MMSET spikes (A) or CCND1 spikes (B) according to the presence or absence of Amp1q21. Note that the difference in median follow-up of this group of patients is different from the overall group because microarray profiling was initiated after Total Therapy 2 had started.